Author

David W. Vredevoogd

The Netherlands Cancer InstituteORCID 0000-0001-6718-1422Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anastasia PiskopouiD· 1 shared Daniel S. PeeperiD· 1 shared Kelly E. SteckeriD· 1 shared Maarten A. F. AltelaariD· 1 shared Xiangjun KongiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Anastasia PiskopouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologybioRxivPreprintMay 20, 2025

Inhibition of TBK1/IKKe mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing

Anastasia Piskopou, David W. Vredevoogd, Xiangjun Kong…·Kelly E. Stecker

This study shows that inhibiting TBK1/IKKe-mediated RIPK1 phosphorylation increases tumor sensitivity to immune cell killing by disrupting TNF signaling.

3 citations

humanexperimental assay

𝕏 PostBluesky